Retrieve Medical Holdings Inc

Retrieve Medical Holdings Inc has a negative equity position of $-300,160 million, indicating a significant financial distress, and a debt-to-equity ratio of -0.21, which suggests that the company is financed more by debt than equity. The company's liquidity is further strained by a current ratio of 0.0, meaning it has no current assets to cover its current liabilities. The negative operating cash flow of $-60 million indicates that the company is not generating sufficient cash from its operations to sustain its activities. The company's profitability is severely challenged, with a net income of $-42,710 million and an operating income of $-40,210 million. The return on equity of 14.23% is unusually high given the negative equity, and the return on assets of -122.03% indicates that the company is not effectively using its assets to generate profit. These metrics are far below the industry norms for a software company, suggesting a significant underperformance relative to its peers. The company's revenue is not segmented by product or geographic region in the available data, making it difficult to assess the concentration of its revenue streams. However, the lack of detailed segment data implies that the company may be overly reliant on a single product or market, which could pose a concentration risk. The company's growth trajectory is uncertain, as there are no specific revenue growth projections provided in the available data. The negative operating income and net income suggest that the company is not currently in a growth phase and may be struggling to achieve profitability. The absence of detailed growth metrics makes it challenging to assess the company's future prospects. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt indicates that the company is not in a position to meet its short-term obligations without additional financing. The low dilution risk suggests that the company is not expected to issue a significant number of new shares in the near term, which could help maintain shareholder value. There are no recent events or filings mentioned in the available data that would provide insight into the company's current operations or strategic direction. The lack of recent disclosures makes it difficult to assess any material changes in the company's business or financial condition.